Anthropic’s pending IPO may arrive in October, but its small weight in ETFs and lack of public financials make buying those funds for Anthropic exposure premature.
Anthropic could launch an initial public offering as early as October, prompting investors to seek ways to gain exposure before shares trade publicly. One method highlighted is purchasing exchange‑traded funds that already hold a portion of the company’s private stock.
A Bloomberg report from mid‑August identified at least eight U.S.-listed ETFs that own Anthropic directly. The KraneShares Artificial Intelligence and Technology Public‑Private ETF (AGIX) holds about 1.2% of its portfolio in Anthropic, while the Alger Concentrated Equity ETF (CNEQ) has the highest weighting at roughly 5.2%. At those levels, a $10,000 investment would translate to about $121 or $520 of Anthropic exposure, respectively, and investors would also incur the funds’ expense ratios (1.00% for AGIX, 0.56% for CNEQ).
The article notes that key company details remain unavailable: as of Sept. 16 there is no public S‑1 filing, no announced IPO date, target price range, or ticker symbol. Although Anthropic disclosed an annual revenue run rate of $65 billion in August, those figures are likely adjusted and may not align with GAAP numbers that will appear in the prospectus. Consequently, buying ETF shares now would commit capital to an asset whose fundamentals cannot yet be verified.
Given the missing prospectus and definitive financial data, the source advises investors to wait for the full information before deciding whether to purchase Anthropic stock after the IPO, leaving the timing and terms of the offering uncertain.